Merck wants your Tired, your Poor to be ‘One Less’ Gardasil Access Program Targets Third World Countries

SEO Press Releases

North Hollywood, California, June 24, 2010Vaccine Adverse Reporting System (VAERS) May statistics on HPV vaccine injury and death now stands at 18,445 adverse reaction (increase of 1,000 in the last 6 weeks), 75 deaths, 3,771 not recovered, 4,905 unknown recovered, 610 disabled, 355 life threatening, 7,858 ER visits, 1,865 hospitalized. The numbers reflect only 1 to 10% of the population reporting.

Recent news stories have reported that only 1/3 of girls in the U.S. are getting vaccinated. With the FDA’s blessing, Merck is now actively pursuing 9 to 26 year old boys – and reports of adverse events are now coming in.

If this is not enough cause for concern, the Gardasil Access Program, a five-year organized effort between Merck & Company, Axios Healthcare Development (AHD) and Axios International is now donating 3 million doses of the vaccine to low-income countries around the world.

As reported in the June 13 Vaccine Examiner article, Merck targets low-income countries for further HPV vaccination ‘projects’ , 72 countries are eligible for the program and with a downloadable application form for organizations and institutions in these low-income countries to use.

The April 10 Gardasil Access Program states that by December 2009 18 applications from 17 countries Bhutan, Bolivia, Cambodia, Cameroon, Georgia, Ghana, Haiti, India, Kenya, Lesotho, Moldova, Nepal, Nicaragua, Papua New Guinea, Tanzania, Uganda, Uzbekistan have been approved. Merck has pledged 496,000 doses of Gardasil enough to vaccinate over 165,000 girls with the full series (3 shots) over a 6-month period. By March 302,400 doses of Gardasil shipped to 9 of the 18 “beneficiaries” enough to vaccinate over 100,000 girls. The newsletter also lists 72 low-income countries eligible for the vaccine. (TAG) is aware that cervical cancer is a concern in majority world countries.  According to the newsletter 80% of the world’s cervical cancers occur in these low income countries.

Vaccinating vulnerable populations with potentially thousands of adverse reactions and/or deaths without proper health care access or injury monitoring systems is a serious issue.

What messages will be given to these girls to encourage their participation in the program?  Will they be the same as in India where unsuspecting girls and boarding school wardens and parents were told that the free expensive vaccines provide life-long protection to prevent ‘uterine’ or ‘cervical cancer’ with no side-effects or impact on fertility?

Will parents have informed consent, or will they be given English HPV Immunization Cards’ a language that they cannot speak? According to the newsletter, seeking parental consent in Bolivia (not normally required for vaccination) “discouraged confidence and acceptance of the vaccine.”

TAG is demanding investigations and accountability for the vaccine injuries and deaths in this country and in other developed countries before the vaccine programs in low income countries be implemented. Nothing is for free – and in this case, the price tag may be ‘one less’ healthy third world girl.


Contact Information

Bobbi Cowan Public Relations
North Hollywood
Phone: (818) 980-2372
Visit Website



Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.